Leaflet CETROTIDE 3mg powder and solvent for solution for injection

Product code:
W06897001
Quantity:
1
Indicated for:
infertility
Route of administration:
injectable
Substance:
cetrorelix (GnRH antagonist)
ATC
H01CC02 — Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Anti-gonadotropin-releasing hormones
Cetrorelix is a gonadotropin-releasing hormone (GnRH) antagonist primarily used in reproductive medicine to prevent premature ovulation in women undergoing assisted reproductive techniques, such as in vitro fertilization (IVF). It works by blocking GnRH receptors, thereby inhibiting the secretion of luteinizing hormone (LH).

The medication is administered as a subcutaneous injection, usually during the follicular phase of the menstrual cycle, as directed by a specialist. The dosage and duration of treatment are adjusted based on the patient's response.

Patients should be closely monitored to assess ovarian response and detect potential side effects. It is important for patients to adhere to the treatment schedule and inform their doctor of any unusual symptoms.

Common side effects include injection site reactions, nausea, headache, and abdominal discomfort. In rare cases, severe allergic reactions or ovarian hyperstimulation syndrome may occur. Patients should be informed of these risks before starting treatment.

General data about CETROTIDE 3mg

Substance:
cetrorelix
Date of latest medicines list:
01-07-2015
Product code:
W06897001
Concentration:
3mg
Pharmaceutical form:
powder and solvent for solution for injection
Quantity:
1
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Concentrations available for cetrorelix

  • 0.25mg
  • 3mg